Elm Street Ventures’ Portfolio Company Saphlux, Inc. Raises $5 Million in Additional Funding
Elm Street Ventures announced today that it has increased its investment in Saphlux, Inc. as part of a $5 million Series AA financing round.
Recent Posts
- Stradefy Biosciences Appoints Jeffrey M. Goldberg as Executive Chair
- P2 Science appoints Oihana Elizalde, PhD as Chief Executive Officer
- CellFE secures $22 million in Series A financing
- Yale Announces Major Upgrade to Engineering Campus
- Desmos Sells Curriculum Business to Amplify Education and Spins Out Desmos Studio PBC